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Background: Although depression symptoms are often experienced by individuals who
develop posttraumatic stress disorder (PTSD) following trauma exposure, little is know
about the biological correlates associated with PTSD and depression co-morbidity vs.
those associated with PTSD symptoms alone.
Methods: Here we examined salivary cortisol responses to trauma activation in a
sample of 60 survivors of the World Trade Center attacks on September 11, 2001.
Participants recalled the escape from the attacks 7 months post 9/11. Salivary cortisol
levels were measured before and after their recollection of the trauma. PTSD, depression,
and somatic symptoms were also assessed. From the behavioral assessment scales,
the participants were grouped into three conditions: those with comorbid PTSD and
depressive symptoms, PTSD alone symptoms, or no-pathology.
Results: Baseline and cortisol response levels differed between the comorbid, PTSD
alone, and no-pathology groups. Individuals endorsing co-morbid symptoms had higher
PTSD and somatic symptom severity and their cortisol response decreased following
their trauma reminder while a trend of an elevated response to the trauma was found in
the PTSD alone group. Our findings show distinct psychological and biological correlates
related to the endorsement of PTSD with and without depression comorbidity.
Conclusions: The findings suggest that comorbidity symptoms manifestation entails a
separate trauma induced condition from PTSD. Future research on biological correlates
of comorbid PTSD and depression is warranted.
Keywords: PTSD symptoms, depressive symptom, September 11 terrorist attacks, cortisol, traumatic stress
INTRODUCTION
A significant number of individuals who encounter a traumatic event during the course of their lives
experience temporary psychiatric symptoms, yet some go on and develop enduring and debilitating
psychiatric conditions. Posttraumatic stress disorder (PTSD) is the most commonly associated
disorder induced by trauma exposure (Breslau et al., 1997; Dekel et al., 2013b). Furthermore, many
individuals endorsing PTSD report symptoms of depression as well (Kessler et al., 1995; O’Donnell
et al., 2004), with comorbidity as high as 70% of the cases (Dekel et al., 2014). Considerable
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research has documented that the clinical expression of comorbid
depression and PTSD differs from the presentation of PTSD
alone (Sher, 2005). Comorbidity is associated with greater trauma
exposure (Morina et al., 2013), PTSD symptom severity (Ikin
et al., 2010), higher level of impairment (Mollica et al., 1999),
sucidiality (Oquendo et al., 2003), and more hospitalizations
(Sher, 2005). Depression may further mediate and intensify
associated symptoms of PTSD such as somatization (Gupta,
2013) and contribute to an enduring sense of perceived threat
(Lancaster et al., 2016). Although this clinical expression of the
comorbidity condition suggests a more severe and enduring
pathology, associated (unique) biological factors are relatively
unknown. The present study explored potential differences in the
biological stress response of individuals with PTSD and those
endorsing PTSD as well as depressive symptoms.
The hypothalamic-pituitary adrenocortical (HPA) axis is an
important part of the biological response to stress, promoting
adaptation and accommodation to threatening and traumatic
exposure (Gillespie et al., 2009). Stress exposure triggers a cascade
of events in HPA activity with the end product being the release
of the glucocorticoid hormone cortisol. Cortisol is generally
elevated following trauma exposure (Kotozaki and Kawashima,
2012). In the short run cortisol facilitates the stress response and
promotes the system’s homeostasis and allostasis (Schulkin et al.,
1994). However, prolonged activation of the HPA response can
result in aggregated physiological and psychological wear and
tear (McEwen, 2003). Cortisol abnormalities are associated with
PTSD alone and depression alone (Morris et al., 2012b), but
little is know about the cortisol pattern in comorbid PTSD and
depression.
Neuroendocrine studies have consistently found cortisol
variations in PTSD, which may in part account for the
pathogenesis of the disorder. In general, cortisol (basal)
abnormalities in PTSD have been largely manifested in
hypoactivation of the system. Individuals with PTSD following
a single traumatic event tend to have lower basal cortisol
levels than healthy or trauma-exposed individuals without PTSD
(Meewisse et al., 2007). The blunted cortisol response in PTSD is
attributed to an enhancedHPA feedback function (Yehuda, 2002)
leading to a progressive sensitization of the HPA-axis (Kendall-
Tackett, 2000). Interestingly, depression is generally associated
with hypercortisolemia (Holsboer, 2001), increased activity of
the HPA axis and reduced inhibitory feedback (Kendall-Tackett,
2000). These findings raise the question whether individuals with
PTSD + depression would differ from individuals with PTSD
based on their HPA stress response.
Studies examined basal cortisol levels in individuals with
co-morbid depression and PTSD reveal mixed findings.
A few studies have documented that their (basal) cortisol
levels are similar to those of healthy individuals, suggesting
that the contrasting HPA patterns in depression and PTSD
“counterbalance” one another when conditions co-occur
(Halbreich et al., 1989). However, other recent studies have
documented, lowered cortisol (basal) levels in the co-morbid
group, as seen in pure PTSD, suggesting that comorbid
depression does not effect the predominant PTSD cortisol
pattern. For example, in a recent meta-analysis lower basal
diurnal cortisol was evident in both PTSD as well as PTSD +
depression groups relative to non-trauma exposed individuals
(Morris et al., 2012a). Similarly, studies using pharmacological
challenge tests [e.g., dexamethasone suppression test (DST)]
for the most part conclude no effects of depression on HPA
activity in PTSD (de Kloet et al., 2006). These results suggest
that individuals with comorbid PTSD and depression resemble
individuals with PTSD alone.
An important factor in understanding trauma-related
disorders is the cortisol response to stressful stimulus
and trauma-related reminders. Psychological distress and
physiological reactivity upon exposure to trauma-related cues
(DSM-5 B.4, B.5) are a salient character of PTSD. The failure of
extinction of fear responsiveness to trauma-related cues is an
underlying feature of the disorder. Responses to trauma stimulus
provide a strong method for examining biological abnormalities
in PTSD and co-morbid conditions. A consistent picture has
emerged demonstrating greater peripheral nervous system
reactivity including autonomic hyper-reactivity to trauma-
related stimuli in individuals who develop PTSD (Dekel et al.,
2016). Examining cortisol response in PTSD under symptom
provocation may therefore offer a more promising assessment
(Pitman et al., 2012) than measures of cortisol at rest.
In contrast to low basal levels, studies examining cortisol
response in PTSD to stressful stimuli and trauma-reminders are
few and for the most part point the direction of augmented
cortisol responses (Liberzon et al., 1999; Bremner et al., 2003;
Elzinga et al., 2003; Dekel et al., 2013a). Although these
augmented cortisol responses are associated with PTSD, the
contribution of comorbid depression symptoms remains unclear.
Depression is associated with a sense of perceived threat
(Lancaster et al., 2016) and may modify cortisol response to
trauma reminder. Somatization symptoms are also frequently
associated with depression and interact with the activity of the
HPA-axis (Rief and Auer, 2000). To the best of our knowledge
no study has compared the cortisol response to trauma-related
reminders in comorbid depression + PTSD to that of PTSD
alone. Thus, in the present study we examined cortisol response
induced by trauma recollections in a sample of high-exposure
9/11 survivors. We initially examined differences in trauma
exposure and symptom severity. We focused our analysis on
the question whether individuals with comorbid PTSD and
depressive symptoms differ from those who suffer from PTSD
alone in their cortisol response.
METHODS
Participants
The present analysis is part of a larger inquiry on psychological
adaption to terrorism of Bonanno et al. (2005). Data at 7 months
(Time 1: March, 2001, [T1]) and 18 months (Time 2: April,
2002, [T2]) post- 9/11 were obtained from individuals who had
been in or within four blocks of the World Trade Center (WTC)
towers at the time of the 9/11 attacks. Following approval from
Columbia University’s Institutional Review Board, we enlisted
participants through their employers in theWTC, posted flyers in
downtown Manhattan, and through public announcements. All
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participants signed written consent forms. The final prospective
sample of individuals with data at the two assessment points
included 60 participants (29 men and 31 women); the average
age was 39.30 years (SD = 10.51), average annual income was
$70,000, ethnically 77% were White (n = 48), and 44% resided
in Manhattan (n = 28). There were no gender differences in
demographics.
Measures
Threat exposure during the event was measured by six items
pertaining to feelings of physical danger and being highly
distressed (“perceived danger”), assessed on a 0= no to 4= very
much; scale (α = 0.83), and four items pertaining to witnessing
deaths and injuries (“objective exposure”), assessed on a 0= none
to 3= three ormore; scale (α between 0.70 and 0.80). Exploratory
factor analysis supported 2-factor structures for the measure at
T1.
PTSD symptoms at T1 and T2 were measured using the PTSD
Symptom Scale-Self Report (PSS-SR, Foa et al., 1993), a 17-
item scale reflecting frequency and severity of PTSD symptoms
according to the Diagnostic and Statistical Manual of Mental
Disorders (American Psychiatric Association, 2013) in the past
month using a 0 (never/rarely) to 3 (almost always) scale. The
PSS-SR has produced adequate internal consistency (.91) and
concurrent validity (Foa et al., 1993). Internal consistency in the
present study was 0.91. Previous research indicates that a PSS-SR
total score of 14 serves as a reliable cutoff score for screening for
PTSD (Coffey et al., 2006).
Depressive symptoms at T1 and T2 were measured using the
Center for Epidemiologic Studies Depression Scale, Brief Version
(CES-D, Kohout et al., 1993), consisting of nine-item scale and
has evidenced reliability and validity statistics comparable to the
full-scale version (Kohout et al., 1993). Respondents used a 1
(hardly ever) to 5 (almost always) scale to indicate how often they
experienced depression symptoms in the past 2 weeks. Internal
consistency for the nine-item scale in the current study was 0.79.
A CES-D total score of 16 is the standard cutoff for low vs. high
depression symptoms.
Somatic symptoms were assessed at T1 with an 18-item self-
report checklist used in the Whitehall II study, a large scale study
of morbidity among civil servants in London, England (Marmot
et al., 1991; Stansfeld et al., 1993).
Trauma recollections were obtained at T1 in a 30-min open-
ended standardized interview asking participants to freely recall
their personal experiences escaping from the attacks prompted
by the instruction: “I would like you to speak about what you
went through on September 11; your experiences, thoughts and
feelings on that day” (Dekel and Bonanno, 2013). Participants
were instructed to report as openly as possible about virtually
anything that came to mind.
Salivary cortisol measured at T1 was collected 2 min before
and after the 30-min interview using Salivette collection devices
(Sarstedt, Newton, NC) and stored at −20◦C. Salivary cortisol
was analyzed by a high-sensitivity cortisol enzyme immunoassay
(Salimetrics, State College, PA) as described in Dozier et al.
(2006). Intra-assay (2.20%) and interassay (5.70%) variability
and pH of the assays were within the range of precision
expected by Salimetrics. Cortisol concentration (µg/dl) was
measured by optical density of duplicate samples using a Dynex
spectrophotometer.
RESULTS
First, we categorized participants as having a high or low number
of symptoms of depression and PTSD. Categorization of a high
vs. low number of depression symptoms was based on the
standard cutoff for the CES-D Scale of 16; categorization of a high
vs. low number of PTSD symptoms was based on the standard
cutoff for PSS-SR Scale of 14. Next, we categorized participants
into one of three psychopathology groups: “comorbid group,”
i.e., high levels of both PTSD and depressive symptoms (n =
18); “PTSD group,” i.e., high levels of PTSD symptoms alone (n
= 15); and “no-pathology group,” i.e., low levels of PTSD and
depressive symptoms (n = 27). Only 3 participants had elevated
depressive symptoms alone (without PTSD) and their data were
not included in the analysis. There were no gender differences
between study groups.
Do the Psychopathology Groups Differ in
the Extent of Perceived Danger and
Objective Exposure to the WTC Attacks?
To examine whether the study groups (comorbid, PTSD only,
and no-pathology) differ in the extent of perceived danger and
objective exposure to WTC attacks, we conducted two separate
tests of one-way analysis of variance (ANOVA). Means, standard
deviations, statistics and effect sizes are presented in Table 1.
The analyses indicated that the study groups significantly
differed in the extent of perceived danger but not in the objective
exposure to the 9/11 events. Sidak post-hoc analyses revealed that
participants classified as comorbid PTSD+ depressive symptoms
TABLE 1 | Means, standard deviations, statistics, and effects sizes for the differences between psychopathology groups in perceived danger and
objective exposure to 9/11 events.
PTSD + Depression (N = 18) PTSD only (N = 15) No-pathology (N = 27)
M SD M SD M SD F(2, 56) η
2
Perceived danger 2.41a 1.30 2.18a 0.99 1.31b 0.98 6.26** 0.18
Objective exposure 1.06 0.79 0.88 0.81 0.67 0.83 1.25 0.04
**p < 0.01. Means with different superscript are significantly different at p < 0.05 based on Sidak adjustment.
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or PTSD alone perceived the danger of the attacks to be higher
than those of the no-pathology group (Šidák, 1967).
Do the Psychopathology Groups Differ in
the Severity of PTSD and Somatic-Related
Symptoms?
To examine whether the study groups (comorbid, PTSD only,
and no-pathology) differ in the intensity of PTSD symptoms 7
and 18 months after the attacks and in somatic symptoms 7
months post the attack, we conducted multivariate analysis of
variance (MANOVA). Means, standard deviations, statistics and
effect sizes are presented in Table 2.
The analysis indicated that the study groups significantly
differed in the multivariate factor of symptom severity, Pillai’s
T = 0.86, F(6,86) = 10.72, p < 0.001. Complementary one-way
ANOVAs and discriminant analysis indicated that the comorbid
group suffered from significantly higher intensity of PTSD
symptoms (7 and 18 months) and somatic-related symptoms
than the PTSD and no-pathology groups, with the largest
differences in PTSD symptoms at 7 months (β = 0.94), followed
by PTSD symptoms at 18 months (β = 0.58), and somatic-
related symptoms at 7 months (β = 0.52). Both the comorbid
and PTSD only groups had higher levels of PTSD symptom and
somatic-related symptom severity than the no-pathology group.
Do the Psychopathology Groups Differ
Significantly in the Cortisol Reactivity to
the WTC Recollections?
First, we examined differences in baseline levels of cortisol
between PTSD groups (PTSD + MDD, PTSD only, resilience),
and we conducted one-way analysis of variance (ANOVA)
with Brown-Forsythe adjustment to account for inequality of
variance (a correction to the degrees of freedom). The analysis
revealed significant results, F(2,25.96) = 3.85, p = 0.034, η
2
=
0.16. Although the effect size was small, planned contrasts with
Bonferroni correction because of non-orthogonal comparisons
indicated that the baseline cortisol level of the PTSD +
depression group (M = 0.17, SD= 0.12) was significantly higher
than that of the PTSD only group (M = 0.10, SD = 0.06, p =
0.048) and/or that of the resilience group (M = 0.10, SD = 0.07,
p= 0.020).
Next, to examine whether the study groups significantly
differed in their cortisol reactivity, we conducted a mixed-
designed analysis of covariance, in which the between-subject
independent variable was study group (comorbid, PTSD only,
no-pathology), the within-subject independent variable was time
(before, after interview), and the dependent variable was level of
cortisol. Because the groups differed in the extent of perceived
danger, we adjusted the analysis for its contribution. Theµg/dl of
salivary cortisol means and standard deviations are presented in
Table 3.
While there were no main effects of group or time, the
analysis revealed a significant interaction between study group
and time, F(2,43) = 4.22, p = 0.021, η
2
p = 0.16. Simple
effects tests with Sidak adjustment revealed distinct differences
in cortisol reactivity between the psychopathology groups
(see Figure 1). Whereas, the cortisol significantly decreased
among the comorbid group, it marginally increased in the
PTSD group (and remained the same among the no-pathology
group).
DISCUSSION
There are two competing theories concerning the tight
relationship between PTSD and depression associated
with trauma exposure (Flory and Yehuda, 2015). First,
the comorbidity manifestation reflects merely overlapping
symptoms of the two conditions, (Southwick et al., 1991;
Franklin and Zimmerman, 2001). Second, comorbid PTSD and
depression represents a distinct trauma-induced phenotype
(O’Donnell et al., 2004; Dekel et al., 2014). We explored
predictions from these theories by measuring cortisol levels
among high-exposure survivors of the WTC attacks in response
to recalling their personal experience escaping from the attack 7
months after the event.
Our study is the first to show that individuals with
comorbid PTSD and depressive symptoms have decreased
TABLE 3 | Means and standard deviations for the differences between
psychopathology groups in cortisol level.
PTSD + Depression PTSD only No-pathology
(N = 18) (N = 15) (N = 27)
M SD M SD M SD
Cortisol level before 0.18 0.12 0.10 0.06 0.10 0.07
Cortisol level after 0.12 0.07 0.15 0.18 0.11 0.08
TABLE 2 | Means, standard deviations, statistics, and effects sizes for the differences between psychopathology groups in PTSD and somatic-related
symptoms.
PTSD + Depression (N = 18) PTSD only (N = 15) No-pathology (N = 27)
M SD M SD M SD F(2, 56) η
2
PTSD (7-months) 28.57a 7.62 19.69b 3.66 7.45c 4.82 61.47*** 0.74
PTSD (18-months) 25.60a 9.36 13.36b 8.15 7.33c 5.44 24.41*** 0.53
Somatic (7-months) 9.21a 2.91 6.15b 2.73 3.70c 2.20 18.87*** 0.46
**p < 0.01. Means with different superscript are significantly different at p < 0.05 based on Sidak adjustment.
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FIGURE 1 | Cortisol reactivity by psychopathology group.
cortisol reactivity following trauma reminder while those with
PTSD symptoms alone and healthy trauma-exposed do not.
A trend of an elevated rather than decreased response to the
trauma reminder was found in the PTSD alone group. The data
also reveal that individuals endorsing comorbid symptoms have
higher PTSD symptoms and somatization than individuals with
PTSD alone.
The findings of comorbid PTSD and depression. Ourelevated
symptoms associated with the comorbid condition indicate that
phenotypically this condition is more severe than PTSD alone,
as previously noted (Sher, 2005). However, the cortisol data
demonstrating differences in baseline and activation cortisol
levels between the comorbid and the PTSD only groups may
suggest distinct conditions and not only one of degree. Our
findings are in accord with the few biological studies comparing
functional and molecular processes, such as lower amygdala
activation (Kemp et al., 2007) and lower epigenetic methylation
(Yehuda et al., 2015) in PTSD alone vs. comorbid PTSD and
depression. Our findings, along with these studies, demonstrate
that individuals with comorbid symptoms differ biologically
from those with PTSD; possibly they all or some suffer from
separate trauma-related psychopathologies. Furthermore, the
differential cortisol responses to retelling the trauma highlight
the importance of trauma-activation, and not only basal cortisol
levels, in accounting for depression associated with PTSD and
PTSD alone psychopathologies.
Baseline levels of cortisol agree fairly well with the general
views of cortisol in major depressive disorder and PTSD
(Yehuda, 2002). That is, baseline cortisol levels of those with
depressive symptomology had higher baseline levels than the
PTSD only group. With the trauma reminder, those with
depressive symptomology had a blunted cortisol response to
trauma-activation, whereas the PTSD only group had a strong
trend toward a sensitized cortisol response to trauma-activation.
While both groups had PTSD symptoms, cortisol levels moved in
different directions after trauma-activation suggesting that when
depressive symptoms are comorbid with PTSD, the depressive
HPA and cortisol mechanisms predominate over the PTSD
mechanisms. Blunt cortisol associated with depressive symptoms
may relate to mechanisms of psychological disengagement with
environmental stressors (Burke et al., 2005) and excessive
shutting down of the hypothalamic-pituitary-adrenal cortical
(HPA) axis due to impairment in negative feedback. An enhanced
cortisol response in PTSD alone may be related with re-
experiencing symptoms (Dekel et al., 2013a). On the other
hand, the comorbidity may have very different pathological
mechanisms than either PTSD or depression alone. These
speculations should be followed up in future research.
Several limitations in this study should be noted. We obtained
only a single post-interview measure of cortisol, and we did not
include information on menstrual cycle, oral contraceptive use,
medications, smoking, eating, and physical exercise just before
the interview. Although we measured PTSD and depressive
symptoms, whether a participant had clinically diagnosed PTSD
or depression was not asked. The small sample size, although
commonly used in studies like ours, raises the possibility of
sample bias, and in the case of baseline cortisol levels, a significant
but small effect size. The study assessed cortisol levels and
responses 7 months post 9/11 and we might have overlooked
variations in the cortisol response associated with symptom
manifestation in the more immediate aftermath of trauma
exposure or in the recovery 18 months after 9/11.
CONCLUSION
In summary, this study demonstrates higher baseline cortisol
levels and lowered HPA-axis response correlates with PTSD +
depressive symptoms and not with PTSD alone in individuals
when confronted by trauma-reminders of the 9/11 WTC
terrorist attacks. Importantly, trauma recollection, even 7
months post-trauma, might be an important tool to assess
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prolonged effects of trauma and their biological correlates.
Biological markers of trauma-related psychopathology may
offer an objective clinical assessment in addition to the
existing DSM mental health classification based on subject
description of symptoms. Further studies are needed to elucidate
distinct biological abnormalities of various trauma-related
conditions. A clearer understanding of unique biological targets
may improve therapeutic interventions for trauma-exposed
individuals endorsing comorbidity symptoms.
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